Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced ...
Nature4y
Nucleic Acids to Amino Acids: DNA Specifies Protein
The simplest way to decipher the code would be to start with an mRNA molecule of known sequence, use it to direct the synthesis of a protein, and then determine the amino acid sequence of the ...
Nanowerk9mon
Nucleic Acids: The Building Blocks of Life
The resulting RNA molecule, typically mRNA, carries the genetic message from the nucleus to the cytoplasm for protein synthesis. Nucleic acids are the foundation of genetic engineering techniques, ...
The Scientist6mon
Biotechs Bolster Biosecurity to Safeguard the Future of Nucleic Acid Sequencing
In response to this gap, leaders in the nucleic acid synthesis industry took a step towards self-regulation. In 2009, they formed the International Gene Synthesis Consortium (IGSC) and established a ...
Nature9mon
Advancing the manufacture of protein and nucleic acid-based biologic vaccines and therapeutics
Primrose Bio intends to apply its broad competencies in nucleic acid synthesis and protein expression to provide novel manufacturing solutions to these molecules as well. By offering affordable ...
Business Wire1mon
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical ...
Business Wire14d
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical ...